Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

Similar articles for PubMed (Select 2419587)

1.

Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus.

Prince GA, Jenson AB, Hemming VG, Murphy BR, Walsh EE, Horswood RL, Chanock RM.

J Virol. 1986 Mar;57(3):721-8. Erratum in: J Virol 1986 Jul;59(1):193.

2.

Novel antigens for RSV vaccines.

Graham BS, Modjarrad K, McLellan JS.

Curr Opin Immunol. 2015 Jun 9;35:30-38. doi: 10.1016/j.coi.2015.04.005. [Epub ahead of print] Review.

PMID:
26070108
3.

Neutralizing epitopes on the respiratory syncytial virus fusion glycoprotein.

McLellan JS.

Curr Opin Virol. 2015 Apr;11:70-75. doi: 10.1016/j.coviro.2015.03.002. Epub 2015 Mar 26. Review.

PMID:
25819327
4.

Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats.

Zhan X, Slobod KS, Jones BG, Sealy RE, Takimoto T, Boyd K, Surman S, Russell CJ, Portner A, Hurwitz JL.

Int Immunol. 2015 May;27(5):229-36. doi: 10.1093/intimm/dxu107. Epub 2014 Dec 4.

PMID:
25477211
5.

An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization.

Raghunandan R, Lu H, Zhou B, Xabier MG, Massare MJ, Flyer DC, Fries LF, Smith GE, Glenn GM.

Vaccine. 2014 Nov 12;32(48):6485-92. doi: 10.1016/j.vaccine.2014.09.030. Epub 2014 Sep 28.

6.

Additive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteins.

Lee S, Quan FS, Kwon Y, Sakamoto K, Kang SM, Compans RW, Moore ML.

Antiviral Res. 2014 Nov;111:129-35. doi: 10.1016/j.antiviral.2014.09.005. Epub 2014 Sep 18.

PMID:
25239522
7.

A monomeric uncleaved respiratory syncytial virus F antigen retains prefusion-specific neutralizing epitopes.

Swanson KA, Balabanis K, Xie Y, Aggarwal Y, Palomo C, Mas V, Metrick C, Yang H, Shaw CA, Melero JA, Dormitzer PR, Carfi A.

J Virol. 2014 Oct;88(20):11802-10. doi: 10.1128/JVI.01225-14. Epub 2014 Jul 30.

8.

Maternal antibodies by passive immunization with formalin inactivated respiratory syncytial virus confer protection without vaccine-enhanced disease.

Kwon YM, Hwang HS, Lee JS, Ko EJ, Yoo SE, Kim MC, Lee YN, Kim KH, Song JM, Lee S, Moore ML, Kang SM.

Antiviral Res. 2014 Apr;104:1-6. doi: 10.1016/j.antiviral.2014.01.008. Epub 2014 Jan 23.

9.

Respiratory syncytial virus fusion glycoprotein expressed in insect cells form protein nanoparticles that induce protective immunity in cotton rats.

Smith G, Raghunandan R, Wu Y, Liu Y, Massare M, Nathan M, Zhou B, Lu H, Boddapati S, Li J, Flyer D, Glenn G.

PLoS One. 2012;7(11):e50852. doi: 10.1371/journal.pone.0050852. Epub 2012 Nov 30.

10.

Evaluation of Measles Vaccine Virus as a Vector to Deliver Respiratory Syncytial Virus Fusion Protein or Epstein-Barr Virus Glycoprotein gp350.

Mok H, Cheng X, Xu Q, Zengel JR, Parhy B, Zhao J, Wang CK, Jin H.

Open Virol J. 2012;6:12-22. doi: 10.2174/1874357901206010012. Epub 2012 Feb 16.

11.

Inactivation of respiratory syncytial virus by zinc finger reactive compounds.

Boukhvalova MS, Prince GA, Blanco JC.

Virol J. 2010 Jan 26;7:20. doi: 10.1186/1743-422X-7-20.

12.

Some Experiments on the Action of Formalin and other Root-dressings.

Simms H.

Proc R Soc Med. 1909;2(Odontol Sect):99-118. No abstract available.

13.

EFFECT OF FORMALIN ON THE VIRUS OF VESICULAR STOMATITIS OF HORSES.

Olitsky PK, Long PH.

J Exp Med. 1928 May 31;47(6):835-41.

14.

Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice.

Fu Y, He J, Zheng X, Wu Q, Zhang M, Wang X, Wang Y, Xie C, Tang Q, Wei W, Wang M, Song J, Qu J, Zhang Y, Wang X, Hong T.

Biochem Biophys Res Commun. 2009 Apr 17;381(4):528-32. doi: 10.1016/j.bbrc.2009.02.075. Epub 2009 Feb 20.

PMID:
19233131
15.

The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes.

Bukreyev A, Yang L, Fricke J, Cheng L, Ward JM, Murphy BR, Collins PL.

J Virol. 2008 Dec;82(24):12191-204. doi: 10.1128/JVI.01604-08. Epub 2008 Oct 8.

16.
17.

Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats.

Mok H, Lee S, Utley TJ, Shepherd BE, Polosukhin VV, Collier ML, Davis NL, Johnston RE, Crowe JE Jr.

J Virol. 2007 Dec;81(24):13710-22. Epub 2007 Oct 10.

18.

Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease.

Castilow EM, Olson MR, Varga SM.

Immunol Res. 2007;39(1-3):225-39. Review.

PMID:
17917067
19.

CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease.

Olson MR, Varga SM.

J Immunol. 2007 Oct 15;179(8):5415-24.

20.

Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.

Elliott MB, Chen T, Terio NB, Chong SY, Abdullah R, Luckay A, Egan MA, Boutilier LA, Melville K, Lerch RA, Long D, Eldridge JH, Parks CL, Udem SA, Hancock GE.

Vaccine. 2007 Oct 10;25(41):7132-44. Epub 2007 Aug 21.

PMID:
17850933
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk